Found: 5
Select item for more details and to access through your institution.
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2).
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 23, p. 3719, doi. 10.3390/cells11233719
- By:
- Publication type:
- Article
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 8, p. 1766, doi. 10.3390/cells9081766
- By:
- Publication type:
- Article
Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.532292
- By:
- Publication type:
- Article
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02070-x
- By:
- Publication type:
- Article
LKB1: Can We Target an Hidden Target? Focus on NSCLC.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.889826
- By:
- Publication type:
- Article